Asston Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Thane, Maharashtra, India, established in 2019.
2019 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited, a active public limited company, was established on 16 April 2019 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24304MH2019PLC324187. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹8.51 Cr.

Its leadership includes Sachin Chandrakant Badakh (Director), Saili Jayaram More (Whole-Time Director), Vijaya E Shahapurkar (Director). Past directors included Saili Jayaram More, Ashish Narayan Sakalkar, Deven Manohar Patil. It holds ₹2.48 Cr open charges and ₹4.48 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4Th Floor Office No A-431 Balaji Bhavan, Plot No 42A Sector-11 Cbd Belapur, Navi Mumbai, Thane, Maharashtra, 400614.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304MH2019PLC324187

  • Registration Number

    324187

  • Incorporation Date

    16 April 2019

  • Authorized Capital

    ₹11.00 Cr

  • Paid-Up Capital

    ₹8.51 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 8.51 Cr
  • Company Age 6 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.48 Cr
  • Satisfied Charges ₹ 4.48 Cr
  • Revenue Growth **** 142.46%
  • Profit Growth **** 213.74%
  • Ebitda **** 35.74%
  • Net Worth 321.12%
  • Total Assets **** 61.48%
Company report

Asston Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Asston Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Asston Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Sachin Chandrakant Badakh Director 17 May 2024 Current
Saili Jayaram More Whole-Time Director 16 Apr 2019 Current
Vijaya E Shahapurkar Director 20 Sep 2024 Current
Rishabh Kumar Jain Director 20 Sep 2024 Current
Ashish Narayan Sakalkar Managing Director 16 Apr 2019 Current
Yogesh Prakash Supekar Additional Director 16 Oct 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Sep 2024 Past
Pramod Abcsdd Director 19 Sep 2024 Past
Pramod Abcsdd Cfo - Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Asston Pharmaceuticals.

Asston Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 142.46% increase. The company also saw a substantial improvement in profitability, with a 213.74% increase in profit. The company's net worth Soared by an impressive increase of 321.12%.

Asston Pharmaceuticals revenue growth over time
Asston Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 142.46%
*******
*******
*******
*******
Revenue from Operations
*******
 143.12%
*******
*******
*******
*******
Total Assets
*******
 61.48%
*******
*******
*******
*******
Profit or Loss
*******
 213.74%
*******
*******
*******
*******
Net Worth
*******
 321.12%
*******
*******
*******
*******
EBITDA
*******
 35.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Asston Pharmaceuticals?

In 2024, Asston Pharmaceuticals had a promoter holding of 72.07% and a public holding of 27.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹24,840,000.00

Satisfied Charges

₹44,800,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 2.21 Cr
  • Others : 0.27 Cr
Latest Charge Details
Date Lender Amount Status
30 Oct 2025 Hdfc Bank Limited ₹2.21 Cr Open
30 Jul 2022 Others ₹2.74 M Open
16 Nov 2022 Others ₹7.80 M Satisfied
01 Jan 2022 Others ₹1.50 Cr Satisfied
18 Dec 2020 Others ₹7.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Asston Pharmaceuticals?

Unlock and access historical data on people associated with Asston Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Asston Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asston Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Asston Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Rishi Upadhaya was appointed as a Company Secretary was appointed as a Company Secretary on 11 Nov 2025 & has been associated with this company since 3 months 2 days . was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.21 Cr with Charge ID 101190397 was registered on 30 Oct 2025. was recorded as a recent event.

  • Director Appointment

    Yogesh Prakash Supekar was appointed as a Additional Director was appointed as a Additional Director on 16 Oct 2025 & has been associated with this company since 3 months 28 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Asston Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Asston Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Saili Jayaram More was appointed as a Ceo was appointed as a Ceo on 04 Oct 2024 & has been associated with this company since 1 year 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Asston Pharmaceuticals Limited?

The CIN of Asston Pharmaceuticals Limited is U24304MH2019PLC324187.

Where is Asston Pharmaceuticals Limited headquartered?

Asston Pharmaceuticals Limited is headquartered at 4Th Floor Office No A-431 Balaji Bhavan, Plot No 42A Sector-11 Cbd Belapur, Navi Mumbai, Thane, Maharashtra, 400614.

When was Asston Pharmaceuticals Limited incorporated?

Asston Pharmaceuticals Limited was incorporated on 16 April 2019.

Who are the current directors of Asston Pharmaceuticals Limited?

The current directors of Asston Pharmaceuticals Limited are

What is the primary industry of Asston Pharmaceuticals Limited?

The primary industry of Asston Pharmaceuticals Limited is Manufacturing.

Is Asston Pharmaceuticals Limited a listed company?

Asston Pharmaceuticals Limited is unlisted.

What is the capital structure of Asston Pharmaceuticals Limited?

The authorized capital of Asston Pharmaceuticals Limited is ₹11.00 Cr, and the paid-up capital is ₹8.51 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available